LGALS1 and hepatocellular carcinoma: Although the question of which source of galectin-1 (tumour hepatocytes or HSCs) contributes more to the progression of HCC has not been answered definitively, our results suggested that HSC-derived galectin-1 promotes HCC progression at least in part by affecting T cells.